LIPOFOR

This brand name is authorized in Cyprus, Hong Kong, Singapore

Active ingredients

The drug LIPOFOR contains one active pharmaceutical ingredient (API):

1 Gemfibrozil UNII Q8X02027X3 - GEMFIBROZIL

Gemfibrozil is a lipid regulating agent which regulates lipid fractions. Gemfibrozil stimulates the peripheral lipolysis of triglyceride rich lipoproteins such as VLDL and cholymicrons by stimulation of LPL. Gemfibrozil also inhibits synthesis of VLDL in the liver. Read about Gemfibrozil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LIPOFOR Film-coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AB04	Gemfibrozil	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AB Fibrates
Discover more medicines within C10AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 43457, 50342
Country: SG	Health Sciences Authority	Identifier(s): 05607P